ABBOTT LABORATORIES (ABT) Return on equity 2016–2025
ABBOTT LABORATORIES (ABT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
12.5%FY2025 · since FY2016: 6.8% → 12.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 12.5% | -15.6 pp |
| FY2024 | 28.1% | +13.3 pp |
| FY2023 | 14.8% | -4.1 pp |
| FY2022 | 18.9% | -0.9 pp |
| FY2021 | 19.8% | +6.0 pp |
| FY2020 | 13.7% | +1.9 pp |
| FY2019 | 11.9% | +4.1 pp |
| FY2018 | 7.8% | +6.2 pp |
| FY2017 | 1.5% | -5.3 pp |
| FY2016 | 6.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice